Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 7 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2

5(62.5%)

Phase 1

2(25.0%)

Phase 4

1(12.5%)

8Total

Phase 2(5)

Phase 1(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT01430234Phase 4Completed

Enzyme Suppletion in Exocrine Pancreatic Dysfunction

Role: collaborator

NCT00322699Phase 1Completed

Sequential Whole Bladder Photodynamic Therapy (WBPDT) in the Management of Superficial Bladder Cancer

Role: collaborator

NCT00862901Phase 1Completed

Safety Study Using Photodynamic Therapy Light Therapy for Patients With Chest Wall Progression of Breast Cancer and Satellite Metastases of Melanoma

Role: collaborator

NCT00308399Phase 2Completed

A Study to Evaluate the Effect of a Medicine on Gastric Functions in Healthy Volunteers.

Role: collaborator

NCT00559052Phase 2Completed

An Open-Label Study to Evaluate the Intraduodenal Delivery of Enzymes From Administration of VIOKASE16 in Exocrine Pancreatic Insufficiency (EPI)

Role: lead

NCT00134758Phase 2Unknown

Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) Patients

Role: collaborator

NCT00470171Phase 2Completed

Pilot Study of Ursodesoxycholic Acid in Non-Alcoholic Steatohepatitis

Role: lead

NCT00490620Phase 2Completed

Study of Combivir for Patients With Primary Biliary Cirrhosis

Role: collaborator

All 8 trials loaded